MES Engineer
Eli Lilly and Company1 day ago
Pleasant Prairie, WI, USAMid Level
Base Salary
$66k - $158k/yr
Responsibilities
- Design, develop, implement, enhance, and maintain MES solutions integrating manufacturing processes with business systems.
- Test, troubleshoot, maintain, and support MES operations to ensure system reliability and data accuracy.
- Own day-to-day MES operations at the manufacturing site as a Tech@Lilly Process Team member.
- Ensure MES processes comply with FDA guidelines, GMP requirements, Lilly policies, and local procedures.
- Document processes and procedures, collaborate with cross-functional teams, and implement digital solutions and continuous improvements.
Requirements
- Bachelor’s degree in Software Engineering, Computer Science, Computer Engineering, Information Systems, or a related engineering field is required.
- Strong understanding of GxP manufacturing processes and practices is required.
- Experience with MES technologies such as MasterControl, Rockwell Automation PharmaSuite, Emerson Syncade, Siemens Camstar, or Werum PAS-X is required.
- Preferred qualifications include a related master’s degree, expertise with ISA-95, OPC, and data historians, and experience integrating MES with ERP and SCADA systems.
- Preferred qualifications include knowledge of MES cybersecurity, GMP and FDA pharmaceutical regulations, computer system validation, solution lifecycle delivery, technical mentoring, and global operations.
Benefits
- Full-time employees may be eligible for a company bonus, 401(k), pension, vacation, medical, dental, vision, prescription drug, flexible spending, life insurance, leave, and well-being benefits.
- The role is Monday through Friday and based on-site in Pleasant Prairie, Wisconsin, with occasional extended-hour or off-hour work and travel to other U.S. and global Lilly sites.
Categories
About Eli Lilly and Company
Eli Lilly and Company researches, develops, manufactures, and markets prescription medicines and biologics for patients, sold through healthcare providers, pharmacies, and payers. Core therapeutic areas include diabetes, oncology, immunology, neuroscience, and obesity. Founded in 1876 and headquartered in Indianapolis, it is a public company (NYSE: LLY) with global operations and is building a new advanced manufacturing site for gene therapy and other modalities in Lebanon, Indiana.